Your browser doesn't support javascript.
loading
Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial.
Subbiah, Vivek; Wolf, Jürgen; Konda, Bhavana; Kang, Hyunseok; Spira, Alexander; Weiss, Jared; Takeda, Masayuki; Ohe, Yuichiro; Khan, Saad; Ohashi, Kadoaki; Soldatenkova, Victoria; Szymczak, Sylwia; Sullivan, Loretta; Wright, Jennifer; Drilon, Alexander.
  • Subbiah V; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: vsubbiah@mdanderson.org.
  • Wolf J; Department of Internal Medicine, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Konda B; Division of Medical Oncology, Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Kang H; Department of Medicine, University of California, San Francisco, CA, USA.
  • Spira A; Department of Medical Oncology, Virginia Cancer Specialists, US Oncology Research, Fairfax, VA, USA.
  • Weiss J; Division of Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, NC, USA.
  • Takeda M; Department of Medical Oncology, Kindai University Hospital, Osaka, Japan.
  • Ohe Y; Department of Thoracic Oncology, National Cancer Centre Hospital, Tokyo, Japan.
  • Khan S; Department of Medical Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Ohashi K; Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Soldatenkova V; Eli Lilly and Company, Indianapolis, IN, USA.
  • Szymczak S; Eli Lilly Polska, Warsaw, Poland.
  • Sullivan L; Eli Lilly and Company, Indianapolis, IN, USA.
  • Wright J; Eli Lilly and Company, Indianapolis, IN, USA.
  • Drilon A; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
Lancet Oncol ; 23(10): 1261-1273, 2022 10.
Article en En | MEDLINE | ID: mdl-36108661
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article